Citations

Showing 10 of 108083 citations.

The benefit of sharing
Heimbach, Julie K.

Mayo Clinic

Hepatology | August 14, 2017 | Volume: 67 | Issue: 1 | Pages: 16-17

10.1002/hep.29467 | PMID 28806474 Get It

Anterior Cruciate Ligament Tunnel Placement Using the Pathfinder Guide
Patel, Karan A. , Makovicka, Justin L. , Piasecki, Dana P., Hartigan, David E. , Bingham, Joshua, Patel, Karan , Chhabra, Anikar , Bingham, Joshua S.

Mayo Clinic

Arthroscopy Techniques | August 14, 2017 | Volume: 6 | Issue: 4 | Pages: No page available

10.1016/j.eats.2017.05.009 | PMID 29354431 Get It

Abstract Reconstruction techniques for the anterior cruciate ligament (ACL) have evolved considerably over the past 3 decades. The femoral tunnel is most commonly made via a transtibial or separate anteromedial portal approach. Benefits and drawbacks for each of these techniques exist. Improper tunnel placement is the cause of failure for ACL reconstruction 70% of the time. We present a hybrid technique for femoral tunnel placement using the Pathfinder ACL guide, which attempts to give the surgeon many of the benefits of both the transtibial and anteromedial portal techniques without the drawbacks. Technique Video video See video under supplementary data.
Ammonia Levels and Hepatic Encephalopathy in Patients with Known Chronic Liver Disease
Ninan, Jacob , Feldman, Leonard Samuel , Ninan, Jacob

Mayo Clinic

Journal of Hospital Medicine | August 14, 2017 | Volume: 12 | Issue: 8 | Pages: 659-661

10.12788/jhm.2794 | PMID 28786433 Get It

The “Things We Do for No Reason” series reviews practices which have become common parts of hospital care but which may provide little value to our patients. Practices reviewed in the TWDFNR series do not represent “black and white” conclusions or clinical practice standards, but are meant as a starting place for research and active discussions among hospitalists and patients. We invite you to be part of that discussion.
Letter: the definition of budesonide dependence in microscopic colitis—authors’ reply
Cotter, Thomas G. , Kamboj, Amrit K. , Hicks, Stephen B., Tremaine, William J., Loftus, Edward V. , Pardi, Darrell S. , Cotter, T G , Pardi, D S , Loftus, Edward V

Mayo Clinic

Alimentary Pharmacology & Therapeutics | August 14, 2017 | Volume: 46 | Issue: 6 | Pages: 636-636

10.1111/apt.14239 | PMID 28805323 Get It

Linked ContentThis article is linked to Cotter et al and Fernández‐Bañares and Gisbert papers. To view these articles visit https://doi.org/10.1111/apt.14133 and https://doi.org/10.1111/apt.14220.
Hitting the Holy Grail of Hematopoietic Cell Transplantation with Naive T-Cell Depleted Allografts—Graft Engineered Hematopoietic Stem Cell Transplant
Fakih, Riad El , Hashmi, Shahrukh, Hashmi, Shahrukh K.

Mayo Clinic

Biomedicines | August 14, 2017 | Volume: 5 | Issue: 3 | Pages: 48

10.3390/biomedicines5030048 | PMID 28805723 Get It

Hematopoietic cell transplant is a potentially curative procedure for many benign and malignant conditions. The efficacy of allogeneic transplant relies in part on the cytotoxicity of the conditioning regimen and the graft versus tumor effect mediated by alloreactive donor T cells; the same cells are also implicated in the development of graft versus host disease (GVHD). Selective identification and depletion of the T cells implicated in GVHD, while preserving the T cells responsible for graft versus tumor effect has been the focus of many research groups in the recent years. Here we briefly review the physiology of T cells in transplantation, and comment on a recent clinical trial published by Bleakly et al. using a novel way of graft engineered allograft via naïve T cell depletion.
Horizontal Cleavage Meniscus Tear Treated With All‐inside Circumferential Compression Stitches
Johnson, Joshua D. , Wu, Isabella T. , Saris, Daniël B.F. , Krych, Aaron J. , Woodmass, Jarret M, Krych, Aaron J , Woodmass, Jarret Murray , Stuart, Michael J.

Mayo Clinic

Arthroscopy Techniques | August 14, 2017 | Volume: 6 | Issue: 4 | Pages: No page available

10.1016/j.eats.2017.05.016 | PMID 29354436 Get It

Abstract Horizontal cleavage meniscus tears are a common orthopedic injury often treated with partial or total meniscectomy versus repair. This Technical Note presents a technique for all‐inside repair with uniform compression of the superior and inferior leaflets by placement of multiple circumferential compression stitches using an all‐inside self‐retrieving suture passing device. The currently described technique provides several advantages for all‐inside repair of a horizontal cleavage tear: (1) eliminates the need for a posterior incision, (2) minimizes the risk of neurovascular injury, (3) uses standard arthroscopy portals (or small modifications), and (4) requires only a single suture deployment with a self‐retrieving device for each circumferential compression stitch. The resulting circumferential stitch provides uniform compression to the superior and inferior leaflets, promoting meniscal healing. This configuration has been shown to have the highest load to failure of all repair patterns. Technique Video video See video under supplementary data.
Neurological Manifestations of X-Linked Ichthyosis: Case Report and Review of the Literature
Baek, William S. , Aypar, Umut

Mayo Clinic

Case Reports in Genetics | August 13, 2017 | Volume: 2017 | Issue: No issue available | Pages: 1-5

10.1155/2017/9086408 | PMID 28884032 Get It

A 5-year-old boy presented with mild autism and attention-deficit hyperactivity disorder (ADHD). Chromosomal microarray demonstrated a 1.7 Mb deletion at Xp22.31, which was consistent with X-linked ichthyosis (XLI). Further exam revealed dry, scaly skin on his abdomen and pretibial areas. Patients with mutations involving solely the STS gene or the recurrent ~2 Mb deletion may present with ADHD, whereas those with larger deletions including the NLGN4 gene can present with both ADHD and autism. However, our patient presented with mild autism in addition to ADHD despite having only the recurrent deletion without loss of NLGN4. Such neurological manifestations of XLI warrant attention as practical targets of clinical management.
Atypical parkinsonian syndromes: a general neurologist's perspective
Deutschländer, Angela , Ross, Owen A. , Wszołek, Zbigniew K. , Deutschländer, A B , Wszolek, Z.K. , Ross, Owen A , Dickson, Dennis W.

Mayo Clinic

European Journal of Neurology | August 13, 2017 | Volume: 25 | Issue: 1 | Pages: 41-58

10.1111/ene.13412 | PMID 28803444 Get It

The differential diagnosis of atypical parkinsonian syndromes is challenging. These severe and often rapidly progressive neurodegenerative disorders are clinically heterogeneous and show significant phenotypic overlap. Here, clinical, imaging, neuropathological and genetic features of multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration and frontotemporal lobar degeneration (FTLD) are reviewed. The terms corticobasal degeneration and FTLD refer to pathologically confirmed cases of corticobasal syndrome and frontotemporal dementia (FTD). Frontotemporal lobar degeneration clinically presents as the behavioral variant FTD, semantic variant primary progressive aphasia (PPA), non‐fluent agrammatic variant PPA, logopenic variant PPA and FTD associated with motor neuron disease. While progressive supranuclear palsy and corticobasal syndrome have been called Parkinson‐plus syndromes in the past, they are now classified as FTD‐related disorders, reflecting that they pathologically differ from α‐synucleinopathies like multiple system atrophy and Parkinson disease. The contribution of genetic factors to atypical parkinsonian syndromes is increasingly recognized. Genes involved in the etiology of FTLD include MAPT, GRN and C9orf72. Novel neuroimaging techniques, including tau positron emission tomography imaging, are being investigated. Multimodal magnetic resonance imaging approaches and automated magnetic resonance imaging volume segmentation techniques are being evaluated for optimized differential diagnosis. Current treatment options are symptomatic, and disease modifying therapies are under active investigation.
Gene‐panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication
Toiminen, H., Kvist, Anders , Törngren, Therese , Blomqvist, Carl , Couch, F.J., Aittomäki, Kristiina , Pelttari, L M , Nevanlinna, H , Pelttari, Liisa M. , Shimelis, Hussein , Borg, Alexander , Bützow, Ralf C. , Nevanlinna, Heli

Mayo Clinic

Clinical Genetics | August 12, 2017 | Volume: 93 | Issue: 3 | Pages: 595-602

10.1111/cge.13123 | PMID 28802053 Get It

Gene‐panel sequencing allows comprehensive analysis of multiple genes simultaneously and is now routinely used in clinical mutation testing of high‐risk breast and ovarian cancer patients. However, only BRCA1 and BRCA2 are often analyzed also for large genomic changes. Here, we have analyzed 10 clinically relevant susceptibility genes in 95 breast or ovarian cancer patients with gene‐panel sequencing including also copy number variants (CNV) analysis for genomic changes. We identified 12 different pathogenic BRCA1, BRCA2, TP53, PTEN, CHEK2, or RAD51C mutations in 18 of 95 patients (19%). BRCA1/2 mutations were observed in 8 patients (8.4%) and CHEK2 protein‐truncating mutations in 7 patients (7.4%). In addition, we identified a novel duplication encompassing most of the RAD51C gene. We further genotyped the duplication in breast or ovarian cancer families (n = 1149), in unselected breast (n = 1729) and ovarian cancer cohorts (n = 553), and in population controls (n = 1273). Seven additional duplication carries were observed among cases but none among controls. The duplication associated with ovarian cancer risk (3/590 of all ovarian cancer patients, 0.5%, P = .032 compared with controls) and was found to represent a large fraction of all identified RAD51C mutations in the Finnish population. Our data emphasizes the importance of comprehensive mutation analysis including CNV detection in all the relevant genes.
Neurokinin 3 receptor antagonism decreases gonadotropin and testosterone secretion in healthy men
Skorupskaite, Karolina , Veldhuis, Johannes D. , George, Jyothis T. , Millar, Robert P. , Anderson, Richard A.

Mayo Clinic

Clinical Endocrinology | August 12, 2017 | Volume: 87 | Issue: 6 | Pages: 748-756

10.1111/cen.13445 | PMID 28802064 Get It

SummaryObjectivePatients with mutations of neurokinin B (NKB) and its receptor show hypogonadotrophic hypogonadism, but there is little evidence for the importance of this pathway in reproductive function in normal men, or its functional hierarchy with kisspeptin.DesignAn open label study wherein men (n = 6) were administered the NK3R antagonist MLE4901 40 mg orally twice a day for 7 days. Kisspeptin‐10 (0.3 μg/kg iv bolus) was given before and on day 7 of NK3R antagonist treatment.PatientsSubjects were healthy men.MeasurementsReproductive hormones were measured before and during the NK3R antagonist administration, including frequent sampling on two occasions for analysis of pulsatile LH secretion.ResultsLH, FSH and testosterone secretion were decreased during NK3R antagonist administration. LH showed a biphasic response, being reduced after 24 hours of treatment (4.5 ± 0.6 IU/L pretreatment to 1.7 ± 0.2 IU/L, P < .05), with partial recovery thereafter, but it was again decreased on day 7 (2.5 ± 0.6 IU/L, P < .05 vs pretreatment). FSH secretion was also suppressed, with a similar temporal pattern to that of LH. Testosterone secretion was decreased from 24 hours (18.4 ± 1.6 pretreatment vs 5.6 ± 1.5 nmol/L, P < .01) and remained suppressed throughout the treatment period. Analysis of LH pulsatility showed that both basal and pulsatile LH secretion were markedly suppressed but there was no detected change in LH pulse frequency. Kisspeptin‐10 stimulated LH secretion, with similar responses before and during NK3R antagonist administration.ConclusionsThese data demonstrate a central role for NKB/NK3R in the physiological regulation of reproductive function in men, and that this is functionally upstream of kisspeptin‐mediated GnRH secretion.